LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,634 | 21,221 | 27,760 | 68,353 | 77,219 |
| Marketable Securities | N/A | N/A | N/A | 3,062 | N/A |
| Receivables | 4,153 | 5,834 | 3,929 | 1,843 | 3,552 |
| Inventories | 5,374 | 6,013 | 7,274 | 3,120 | 1,960 |
| TOTAL | $54,265 | $36,456 | $42,203 | $79,170 | $86,114 |
| Non-Current Assets | |||||
| PPE Net | 186 | 215 | 284 | 12,827 | 16,038 |
| Intangibles | 34,608 | 34,996 | 35,384 | 0 | 0 |
| Other Non-Current Assets | 530 | 576 | 2,849 | 15,398 | 16,055 |
| TOTAL | $35,324 | $35,787 | $38,517 | $28,225 | $32,093 |
| Total Assets | $89,589 | $72,243 | $80,720 | $107,395 | $118,207 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,098 | 2,762 | 3,928 | 2,481 | 1,895 |
| Accrued Expenses | 10,414 | 9,184 | 13,847 | 12,513 | 11,324 |
| TOTAL | $11,708 | $12,338 | $18,760 | $17,884 | $16,047 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 188 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 25,746 | 23,555 | 23,054 | 40,317 | 39,437 |
| TOTAL | $150,199 | $147,992 | $147,475 | $164,723 | $163,829 |
| Total Liabilities | $161,907 | $160,330 | $166,235 | $182,607 | $179,876 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,449 | 27,428 | 27,381 | 27,362 | 27,299 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -1,062,334 | -1,076,752 | -1,073,274 | -1,061,514 | -1,045,922 |
| Other shareholders' equity | 3,906 | 3,906 | 3,906 | 3,906 | 3,906 |
| TOTAL | $-72,318 | $-88,087 | $-85,515 | $-75,212 | $-61,669 |
| Total Liabilities And Equity | $89,589 | $72,243 | $80,720 | $107,395 | $118,207 |